Table 51Musculoskeletal diseases: summary of findings

Type of InterventionStudyAdherence:
Measure, Followup Period
Overall Result (+/=/−) and Timing
Additional Outcomes:
Outcome
Overall Result (+/=/−) and Timing
Case managementRudd et al., 2009142
=

Mean score on adherence to treatments scale (0=best, 3=worst)

=

Percentage change at 6 months in medication adherence outcome

=

Percentage change at 12 months in medication adherence outcome

NA
Virtual osteoporosis clinicWaalen et al., 2009143
+

Percentage of women using osteoporosis medication, at 13 months from entry into study

=

Patient satisfaction with care, at 1 year and 30 days from entry into study

Decision aidMontori et al., 2011144
+

Proportion with > 80% adherence, 6 months

=

Proportion of days covered, 6 months

=

Persistence, 6 months

=

Proportion that did not miss a dose, 6 months

=

Started therapy, baseline

=

Mean satisfaction with knowledge transfer

Abbreviations: (+) = statistically significant difference favoring intervention arm(s); (=) = no statistically significant difference; (−) = statistically significant difference favoring comparison arm; N = number.

From: Results

Cover of Closing the Quality Gap: Revisiting the State of the Science (Vol. 4: Medication Adherence Interventions: Comparative Effectiveness)
Closing the Quality Gap: Revisiting the State of the Science (Vol. 4: Medication Adherence Interventions: Comparative Effectiveness).
Evidence Reports/Technology Assessments, No. 208.4.
Viswanathan M, Golin CE, Jones CD, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.